Skip to content
← Full study record

NCT01352286 · FLOW

Participant flow

Redirected Auto T Cells for Advanced Myeloma · Source last updated 2019-12-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants who received lentivirus-mediated genetically engineered NYESO-1ᶜ²⁵⁹T following autologous stem cell transplantation (ASCT)
    id
    FG000
    title
    NYESO-1ᶜ²⁵⁹T Cells Administered Intravenously
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      Received T-cells
    3. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Participants who received lentivirus-mediated genetically engineered NYESO-1ᶜ²⁵⁹T following autologous stem cell transplantation (ASCT)
    id
    FG000
    title
    NYESO-1ᶜ²⁵⁹T Cells Administered Intravenously
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      Received T-cells
    3. achievements
      1. group Id
        FG000
        num Subjects
        25
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice